PRINCIPAL DISPLAY PANEL - 100 mL Bag Label
100 mL
NDC 0409-2776-43
MILRINONE LACTATE INJECTION
20 mg/100 mL (0.2 mg/mL)
IN 5% DEXTROSE INJECTION
SINGLE-DOSE FLEXIBLE CONTAINER
REACH mL CONTAINS MILRINONE LACTATE
EQUIVALENT TO 0.2 mg MILRINONE, 0.282 mg
LACTIC ACID, 49.4 mg DEXTROSE, ANHYDROUS,
USP, IN WATER FOR INJECTION, USP. THE pH IS
ADJUSTED TO BETWEEN 3.2 AND 4.0 WITH LACTIC
ACID OR SODIUM HYDROXIDE. NO
PRESERVATIVES ADDED. USE ONLY IF SOLUTION
IS CLEAR, COLORLESS TO PALE YELLOW AND
CONTAINER IS UNDAMAGED. DISCARD UNUSED
PORTION. EACH FLEXIBLE CONTAINER IS FOR ONE
INFUSION ONLY. FOR INTRAVENOUS USE. USUAL
DOSAGE: SEE INSERT. MUST NOT BE USED IN
SERIES CONNECTIONS.
RX ONLY
IM-5194
3
V
CONTAINS DEHP
Hospira
DIST. BY HOSPIRA, INC., LAKE FOREST, IL 60045 USA
PRINCIPAL DISPLAY PANEL - 100 mL Bag Overwrap Label
TO OPEN — TEAR AT NOTCH
100 mL
NDC 0409-2776-43
Milrinone Lactate Injection
20 mg/100 mL (0.2 mg/mL)
in 5% Dextrose Injection
Each mL contains milrinone lactate equivalent to 0.2 mg milrinone, 0.282 mg
lactic acid, 49.4 mg dextrose, anhydrous, USP, in water for injection, USP.
The pH is adjusted to between 3.2 and 4.0 with lactic acid or sodium
hydroxide. No preservatives added.
Use only if solution is clear, colorless to pale yellow, and container is
undamaged. Single-dose container. For Intravenous Use. Usual dosage: See
insert. Discard unused portion. Each flexible container is for one infusion
only. MUST NOT BE USED IN SERIES CONNECTIONS.
The overwrap is a moisture barrier. Do not remove unit from overwrap until
ready for use. After removing the overwrap, check for minute leaks by
squeezing container firmly. If leaks are found, discard unit as sterility may be
impaired. Use unit promptly when pouch is opened. Store at 20 to 25°C (68 to
77°F). [See USP Controlled Room Temperature.] Protect from freezing.
Rx only
F WR-1548
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Hospira
PRINCIPAL DISPLAY PANEL - 200 mL Bag Label
200 mL
NDC 0409-2776-22
MILRINONE LACTATE INJECTION
40 mg/200 mL (0.2 mg/mL)
IN 5% DEXTROSE INJECTION
SINGLE-DOSE FLEXIBLE CONTAINER
EACH mL CONTAINS MILRINONE LACTATE
EQUIVALENT TO 0.2 mg MILRINONE, 0.282
mg LACTIC ACID, 49.4 mg DEXTROSE,
ANHYDROUS, USP, IN WATER FOR
INJECTION, USP. THE pH IS ADJUSTED TO
BETWEEN 3.2 AND 4.0 WITH LACTIC ACID
OR SODIUM HYDROXIDE. NO
PRESERVATIVES ADDED. USE ONLY IF
SOLUTION IS CLEAR, COLORLESS TO PALE
YELLOW AND CONTAINER IS UNDAMAGED.
DISCARD UNUSED PORTION. EACH
FLEXIBLE CONTAINER IS FOR ONE INFUSION
ONLY. FOR INTRAVENOUS USE. USUAL
DOSAGE: SEE INSERT. MUST NOT BE USED
IN SERIES CONNECTIONS.
Rx ONLY
3
V
CONTAINS DEHP
Hospira
DISTRIBUTED BY
HOSPIRA, INC., LAKE FOREST, IL 60045 USA
IM-5193
PRINCIPAL DISPLAY PANEL - 200 mL Bag Overwrap Label
TO OPEN — TEAR AT NOTCH
200 mL
NDC 0409-2776-22
Milrinone Lactate Injection
40 mg/200 mL (0.2 mg/mL)
In 5% Dextrose Injection
Each mL contains milrinone lactate equivalent to 0.2 mg
milrinone, 0.282 mg lactic acid, 49.4 mg dextrose, anhydrous,
USP, in water for injection, USP. The pH is adjusted to between
3.2 and 4.0 with lactic acid or sodium hydroxide. No preservatives
added.
Use only if solution is clear, colorless to pale yellow, and
container is undamaged. Single-dose container. For Intravenous
Use. Usual dosage: See insert. Discard unused portion. Each
flexible container is for one infusion only. MUST NOT BE USED IN
SERIES CONNECTIONS.
The overwrap is a moisture barrier. Do not remove unit from
overwrap until ready for use. After removing the overwrap,
check for minute leaks by squeezing container firmly. If leaks are
found, discard unit as sterility may be impaired. Use unit promptly
when pouch is opened. Store at 20 to 25°C (68 to 77°F). [See USP
Controlled Room Temperature.] Protect from freezing.
Rx only
F WR-1547
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Hospira
